Evaluation of oral cyclophosphamide activity by CTC enumeration in patients with docetaxel-refractory castration-resistant metastatic prostate cancer: Potential utility in primary refractory disease.
Oscar B. Goodman
No relevant relationships to disclose
James Thomas Symanowski
No relevant relationships to disclose
Louis M. Fink
No relevant relationships to disclose
Nicholas J. Vogelzang
No relevant relationships to disclose